Generic Name and Formulations:
Chlorpheniramine maleate 4mg; tabs.
Merck & Co., Inc.
Indications for CHLOR-TRIMETON:
Allergic and vasomotor rhinitis, conjunctivitis, pruritus.
4mg every 4–6hrs; max 24mg/24hrs.
<6yrs: not recommended. 6–11yrs: 2mg every 4–6hrs; max 12mg/24hrs.
Asthma and lower respiratory disorders. Glaucoma. GI or GU obstruction. Pregnancy, nursing mothers: not recommended.
Potentiates CNS depression with alcohol, other CNS depressants.
Anticholinergic effects, drowsiness, dizziness, paradoxical excitement.
Endocrinology Advisor Articles
- Trends in Cardiovascular Deaths for US Adults With and Without Diabetes
- Diabetic Retinopathy Risk Not Increased With GLP-1 Receptor Agonist Use in T2D
- Concurrent Risk Factors and Microvascular Complications in Type 1 Diabetes
- Comparing Efficacies of Second-Line Treatments in Type 2 Diabetes
- Higher Risk for Meningioma Linked to GH Treatment, Radiotherapy During Childhood
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Hypertension Treatments: ARBs
- Semaglutide vs Liraglutide for Weight Loss in Patients With Obesity
- Liraglutide May Lower Risk for Foot Amputation in Type 2 Diabetes
- Thyroid Hormone Levels, Body Composition, Insulin Resistance in Euthyroid Patients
- Behavioral Weight Loss Interventions May Prevent Obesity
- Disaster Preparedness 101: Physician Resources for Patients
- Assessing the Environmental Impact of the Healthcare Industry
- Medical Schools Phase Out Lectures as Education Shifts Outside the Classroom
- Clonidine Testing Is Safe and Reliable for Diagnosing Growth Hormone Deficiency